Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs desflurane for arterial oxygenation during one-lung ventilation in thoracoscopic lung resection
jRCT1051210194Completed
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in lung neoplasm and bronchial carcinoma (2 arms). Primary endpoint: Minimum PaO2 during one-lung ventilation (first 60 minutes). Started Jun 2022; status: completed.
02
Drugs
remimazolam
03
Conditions
lung neoplasmbronchial carcinoma
Beyond the preview
Go deeper on jRCT1051210194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051210194.